Navigation Links
Thoratec Reports 44 Percent Increase in Third Quarter Revenues

Income (loss)

from operations 8,187 (2,380) 18,404 (3,217)

Other income and


Interest expense (1,009) (1,016) (3,030) (3,158)

Interest income

and other 2,183 2,261 6,642 6,214

Income (loss) before

income taxes 9,361 (1,135) 22,016 (161)

Income tax expense (2,179) (273) (5,834) (269)

Net income (loss) $7,182 $(1,408) $16,182 $(430)

Net income (loss)

per share

Basic $0.13 $(0.03) $0.30 $(0.01)

Diluted $0.12 $(0.03) $0.28 $(0.01)

Shares used to compute

net income per share:

Basic 55,328 53,808 54,702 53,303

Diluted 63,993 53,808 62,979 53,303

The following table reconciles the specific items excluded from GAAP net income in the calculation of non-GAAP net income for the periods shown below:


Reconciliation of GAAP to Non-GAAP Net Income


(in thousands, except for per share data)

Three Months Ended Nine Months Ended

Net income (loss) September 27, September 29, September 27, September 29,

reconciliation 2008 2007 2008 2007

Net income (loss)

on a GAAP basis $7,182 $(1,408) $16,182 $(430)




- Cost of

product sales 371 456 1,284 1,193




- Selling,

general and


SOURCE Thoratec Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Thoratec Schedules Third Quarter 2008 Conference Call, Webcast
2. Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History
3. Thoratec Presentation at JP Morgan Conference to be Webcast
4. Thoratec Announces Appointment of Steven H. Collis to Board of Directors
5. Thoratec Presentation at Bear Stearns Conference To Be Webcast
6. Thoratec Announces HeartMate II(R) PMA Will be Reviewed by FDA Advisory Panel
7. Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results
8. Pharmacyclics Reports First Quarter Fiscal 2009 Financial Results
9. Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008
10. Vanda Pharmaceuticals Reports Third Quarter 2008 Results
11. United Therapeutics Reports Third Quarter 2008 Financial Results
Post Your Comments:
(Date:7/31/2014)... the sound-processing part of the mouse brain in a ... trees in view. Their imaging technique allows zooming in ... and it enabled the team to watch brain cells ... results, which represent a step toward better understanding how ... the journal Neuron . , In the past, ...
(Date:7/31/2014)... 31, 2014 Rogne Bioscience, a privately-held biotechnology ... , has acquired a licence to anti-inflammatory peptides ... The potent anti-inflammatory activity of the peptides was discovered ... of Oxford,s Sir William Dunn School of ... over $1.5 million in seed financing, is developing a ...
(Date:7/31/2014)... , July 31, 2014 Research and ... "Global Genomics Market 2014-2018" report to their offering. ... Genomics is the study of the genetic material or ... a strong basis for the discovery and development of ... diseases or health conditions. Genomics is supported by three ...
(Date:7/31/2014)... SHENZHEN, China , July 31, 2014 ... an Irys™System by BGI , the ... enable comprehensive exploration of human structural variation (SV) and ... interest, including those where no reference exists. In addition, ... methods for multiplexing on the Irys System, enabling significantly ...
Breaking Biology Technology:New mapping approach lets scientists zoom in and out as the brain processes sound 2Oxford licenses anti-inflammatory peptides to San Francisco Bay Area start-up 2Oxford licenses anti-inflammatory peptides to San Francisco Bay Area start-up 3Global Genomics Market 2014-2018: Key Vendors are F. Hoffmann-La Roche, Life Technologies, Qiagen and Illumina 2BioNano Genomics Announces the Purchase of the Irys System by BGI 2BioNano Genomics Announces the Purchase of the Irys System by BGI 3BioNano Genomics Announces the Purchase of the Irys System by BGI 4
... ... performance, cost effective renewable materials for customers which reduce dependency on fossil fuels, ... a broad portfolio of biomaterials and biofuels to global markets at the BIO ... ...
... , June 28 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc.,(Nasdaq: ... China -based biotechnology,company focused on researching, developing, manufacturing ... 25, 2010 , the Company,has filed with the United ... 20-F for the year ended December 31, 2009 ...
... India , June 28, 2010 Shivsu Canadian Clear,International Ltd, a ... from the private organizations and,Government of Africa to set up ... Ethiopia . The company will be involved in design,manufacture, supply and installation of ... ...
Cached Biology Technology:DuPont Leader: Global Demand for Renewable Innovations Growing 2DuPont Leader: Global Demand for Renewable Innovations Growing 33SBio Inc. Announces Filing of Form 20-F With SEC 2Indian Multinational Company Confirms USD 6 Million Order to Set up Industrial Waste Water Treatment Plants in Africa 2Indian Multinational Company Confirms USD 6 Million Order to Set up Industrial Waste Water Treatment Plants in Africa 3
(Date:7/31/2014)... New research, supported by the National Science Foundation ... permafrost uniformly accelerates atmospheric warming, indicating instead that ... they emit into the atmosphere. , The ... Nature , focuses on thermokarst lakes, which occur ... fill with melted fresh water, converting what was ...
(Date:7/31/2014)... NCT00518336) shows the sustained efficacy, immunogenicity and ... vaccine Cervarix. Women vaccinated with the HPV-16/18 ... nine years, and vaccine efficacy (VE) against ... longest follow-up report for a licensed HPV ... full paper. , HPV and vaccination ...
(Date:7/31/2014)... experimental vaccine protected 100 percent of animal models against ... , which causes an intestinal disease that kills approximately ... print in Infection and Immunity . , ... non-human primates against the purified toxins produced by ... spore infection, a laboratory model that mimics the human ...
Breaking Biology News(10 mins):Certain Arctic lakes store more greenhouse gases than they release 2Sustained efficacy, immunogenicity, and safety for GlaxoSmithKline's HPV vaccine 2Sustained efficacy, immunogenicity, and safety for GlaxoSmithKline's HPV vaccine 3C. difficile vaccine proves safe, 100 percent effective in animal models 2
... the name says, is an essential peptide factor for ... can imagine that this growth factor is important for ... report published in the October 7 issue of the ... exciting discovery about this growth factor: NGF is positively ...
... Sept. 5 bioMETRX, Inc. (OTC,Bulletin Board: BMRX) ... announced that it has acquired a patent that ... portable locks. The company believes that this ... many years, consumers have been using portable locks, ...
... the green, rolling hills and farmlands around Lexington, Kentucky, Darrell ... homegrown fertilizer. But hes not looking to grow a better ... Funded by the University of Kentucky and the Homeland Securitys ... something far more sinister. Darrell Taulbee putters with ...
Cached Biology News:Targeting nerve growth factor may cure liver cancer 2bioMETRX, Inc. Acquires Patent for Biometric Padlock 2Brewing a blast-less fertilizer 2
... Rapid-Screen cDNA Library Panels were designed for ... sets of PCRs to identify the desired ... performed in a 96-well "Master Plate," where ... clones. Having identified the positive well(s) by ...
... Unique, compact measuring instrument for calibrating ... compact design and the robust carrying case, ... both in the laboratory and on-site at ... easy to use because the individual channels ...
... HVJ (hemagglutinating virus of Japan, also ... a tool for transfection of molecules by ... are for siRNA (RNAi), Protein, Oligo, cDNA, ... and in vivo. GenomONE-Neo EX has a ...
... S. pombe Whole Genome ChIP-on-chip Microarray ... of yeast (S. pombe) DNA binding ... with Agilent DNA microarrays. This set ... data with greater true binding events ...
Biology Products: